As far as the authors’ clinical practice is concerned, prostate magnetic resonance imaging is a very important test in urology, and in combination with changes in PSA levels, it is almost certain whether patients with benign prostatic hyperplasia or hypertrophy develop prostate cancer. Here, KLK3 is linked to cardiac hypertrophy.